Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=79

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT02513394-deaths",
        "title": "Palbociclib Plus Endocrine Therapy (Arm A) vs Endocrine Therapy Alone (Arm B): deaths from any cause",
        "summary": "99 of 2841 against 76 of 2902; risk difference 0.9 points, 95% interval -0.0 to 1.8; NCT02513394, PALbociclib CoLlaborative Adjuvant Study",
        "record": "/library/comparisons/NCT02513394-deaths",
        "nct_id": "NCT02513394",
        "kind": "deaths",
        "participants": 5743,
        "risk_difference": {
          "value": 0.008658049613673564,
          "lower": -0.0002591633503981096,
          "upper": 0.01770731950877677
        },
        "group_1": "99 of 2,841",
        "group_2": "76 of 2,902",
        "difference": "0.9 points",
        "interval": "-0.0 to 1.8",
        "trial_title": "PALbociclib CoLlaborative Adjuvant Study"
      },
      {
        "id": "NCT02513394-sae",
        "title": "Palbociclib Plus Endocrine Therapy (Arm A) vs Endocrine Therapy Alone (Arm B): serious adverse events",
        "summary": "369 of 2841 against 229 of 2902; risk difference 5.1 points, 95% interval 3.5 to 6.7; NCT02513394, PALbociclib CoLlaborative Adjuvant Study",
        "record": "/library/comparisons/NCT02513394-sae",
        "nct_id": "NCT02513394",
        "kind": "serious-adverse-events",
        "participants": 5743,
        "risk_difference": {
          "value": 0.05097274792099832,
          "lower": 0.035212519950701536,
          "upper": 0.06682325978117512
        },
        "group_1": "369 of 2,841",
        "group_2": "229 of 2,902",
        "difference": "5.1 points",
        "interval": "3.5 to 6.7",
        "trial_title": "PALbociclib CoLlaborative Adjuvant Study"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=80",
  "request_id": "DO7Jk1p08gxISkk0"
}